| scholarly article | Q13442814 |
| P50 | author | Michael A. Fischbach | Q22004359 |
| David Relman | Q26701484 | ||
| P2093 | author name string | Katherine P Lemon | |
| Gary C Armitage | |||
| P2860 | cites work | Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine | Q22250891 |
| Decline of Childhood Haemophilus influenzae Type b (Hib) Disease in the Hib Vaccine Era | Q22253018 | ||
| Probiotics for the prevention of pediatric antibiotic-associated diarrhea | Q24235039 | ||
| Enterotypes of the human gut microbiome | Q24489818 | ||
| From structure to function: the ecology of host-associated microbial communities | Q24612050 | ||
| A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence | Q24650591 | ||
| Dysbiosis in inflammatory bowel disease | Q24685931 | ||
| The application of ecological theory toward an understanding of the human microbiome | Q26825590 | ||
| Interactions Between the Microbiota and the Immune System | Q27028155 | ||
| An inhibitor of FtsZ with potent and selective anti-staphylococcal activity | Q27652237 | ||
| Antibiotic resistance of bacteria in biofilms | Q28207706 | ||
| Factors underlying sensitivity of cancers to small-molecule kinase inhibitors | Q28252845 | ||
| Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis | Q28259055 | ||
| Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis | Q28266275 | ||
| Vaginal microbiome of reproductive-age women | Q28284755 | ||
| Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients | Q29614261 | ||
| An ecological and evolutionary perspective on human-microbe mutualism and disease | Q29614265 | ||
| Host-Gut Microbiota Metabolic Interactions | Q29615104 | ||
| Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation | Q29617796 | ||
| 16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis | Q30860329 | ||
| Ecological consequences of genetic diversity | Q33327408 | ||
| The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review | Q34016487 | ||
| Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). | Q34105840 | ||
| Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies | Q34192717 | ||
| Antibiotic overuse: Stop the killing of beneficial bacteria | Q34210630 | ||
| Keeping their options open: acute versus persistent infections | Q34353792 | ||
| Systematic Review of Intestinal Microbiota Transplantation (Fecal Bacteriotherapy) for Recurrent Clostridium difficile Infection | Q34633079 | ||
| Fecal Transplantation, Through Colonoscopy, Is Effective Therapy for Recurrent Clostridium difficile Infection | Q34634195 | ||
| Clostridium difficile--more difficult than ever | Q34868743 | ||
| Executive summary: the management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. | Q35452403 | ||
| Treatment of infections associated with surgical implants | Q35740678 | ||
| Household versus individual approaches to eradication of community-associated Staphylococcus aureus in children: a randomized trial | Q35771336 | ||
| Predicting a Human Gut Microbiota’s Response to Diet in Gnotobiotic Mice | Q35829905 | ||
| The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins | Q35829917 | ||
| Identification of genes associated with the long-gut-persistence phenotype of the probiotic Lactobacillus johnsonii strain NCC533 using a combination of genomics and transcriptome analysis | Q36594616 | ||
| Intestinal microbial ecology in premature infants assessed with non-culture-based techniques | Q36772933 | ||
| Role of probiotic therapy in IBD. | Q37141846 | ||
| Rules of engagement: interspecies interactions that regulate microbial communities | Q37187806 | ||
| Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates | Q37733964 | ||
| Probiotics in perspective. | Q37802007 | ||
| Probiotics and prebiotics in pediatrics | Q37813322 | ||
| Therapeutic modulation of microbiota-host metabolic interactions. | Q38016806 | ||
| Microbiota, Disease, and Back to Health: A Metastable Journey | Q38016807 | ||
| Staphylococcus aureus nasal carriage in hemodialysis patients. Its role in infection and approaches to prophylaxis | Q38640523 | ||
| Role of probiotic in preventing acute diarrhoea in children: a community-based, randomized, double-blind placebo-controlled field trial in an urban slum | Q39943715 | ||
| Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998-2005. | Q40124157 | ||
| D-amino acids trigger biofilm disassembly | Q42073275 | ||
| Vital signs: preventing Clostridium difficile infections. | Q44610964 | ||
| Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa | Q50561588 | ||
| Does pneumococcal conjugate vaccine influence Staphylococcus aureus carriage in children? | Q51875016 | ||
| Subgingival distribution of Campylobacter rectus and Tannerella forsythensis in healthy children with primary dentition. | Q54656210 | ||
| Biofilms | Q56080242 | ||
| Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease | Q57129932 | ||
| Identification of early microbial colonizers in human dental biofilm | Q60314940 | ||
| Carriage of Haemophilus influenzae type b in children after widespread vaccination with conjugate Haemophilus influenzae type b vaccines | Q64135728 | ||
| Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine | Q68043029 | ||
| Prevalence of Treponema denticola and Porphyromonas gingivalis in plaque from periodontally-healthy and periodontally-diseased sites | Q70459541 | ||
| Progress toward elimination of Haemophilus influenzae type b disease among infants and children--United States, 1987-1995 | Q71796148 | ||
| The microbiota of young children from tooth and tongue samples | Q77587069 | ||
| Effect of antibiotic use on the prevalence of symptomatic vulvovaginal candidiasis | Q77893065 | ||
| Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients | Q82849324 | ||
| Necrotizing enterocolitis | Q83236511 | ||
| Impact of a Guideline on Management of Children Hospitalized With Community-Acquired Pneumonia | Q83479406 | ||
| Preliminary assessment of safety and effectiveness in humans of ProBiora3, a probiotic mouthwash | Q83966109 | ||
| P433 | issue | 137 | |
| P407 | language of work or name | English | Q1860 |
| P6104 | maintained by WikiProject | WikiProject Ecology | Q10818384 |
| P304 | page(s) | 137rv5 | |
| P577 | publication date | 2012-06-01 | |
| P1433 | published in | Science Translational Medicine | Q1573955 |
| P1476 | title | Microbiota-targeted therapies: an ecological perspective | |
| P478 | volume | 4 |
| Q60781844 | A Diet-Sensitive Commensal Lactobacillus Strain Mediates TLR7-Dependent Systemic Autoimmunity |
| Q91639252 | Age-Dependent Dissimilarity of the Nasopharyngeal and Middle Ear Microbiota in Children With Acute Otitis Media |
| Q35185883 | Altered microbiomes in bovine digital dermatitis lesions, and the gut as a pathogen reservoir |
| Q97069843 | An ecological framework to understand the efficacy of fecal microbiota transplantation |
| Q34311624 | Antibiotics and the gut microbiota |
| Q64081818 | Associations of Probiotic Fermented Milk (PFM) and Yogurt Consumption with and Components of the Gut Microbiota in Healthy Adults |
| Q59807752 | Autointoxication and historical precursors of the microbiome-gut-brain axis |
| Q47442713 | Bacterial microbiota of the nasal passages across the span of human life |
| Q35219172 | Bacterial rose garden for metagenomic SNP-based phylogeny visualization. |
| Q42613853 | Cell-based therapeutics: the next pillar of medicine |
| Q38226447 | Challenges of infectious diseases in the USA. |
| Q38207078 | Chronic pulmonary pseudomonal infection in patients with cystic fibrosis: A model for early phase symbiotic evolution |
| Q89304727 | Clindamycin Administration Increases the Incidence of Collagen-Induced Arthritis in Mice Through the Prolonged Impact of Gut Immunity |
| Q39265428 | Clinical Evidence for the Microbiome in Inflammatory Diseases |
| Q90781550 | Colonizing multidrug-resistant bacteria and the longitudinal evolution of the intestinal microbiome after liver transplantation |
| Q36070542 | Commensal-Pathogen Interactions along the Human Nasal Passages |
| Q34274976 | Compositional and functional features of the gastrointestinal microbiome and their effects on human health |
| Q35886154 | Corynebacterium accolens Releases Antipneumococcal Free Fatty Acids from Human Nostril and Skin Surface Triacylglycerols. |
| Q26783837 | Current and future prospects for CRISPR-based tools in bacteria |
| Q36163849 | Data Mining of Lung Microbiota in Cystic Fibrosis Patients |
| Q34625923 | Determining microbial products and identifying molecular targets in the human microbiome |
| Q28273307 | Developing a metagenomic view of xenobiotic metabolism |
| Q34662065 | Ecological theory as a foundation to control pathogenic invasion in aquaculture |
| Q35064587 | Ecotoxicology inside the gut: impact of heavy metals on the mouse microbiome. |
| Q30664039 | Engineering the gut microbiota to treat hyperammonemia. |
| Q38055899 | Environmental factors influencing the efficacy of probiotic bacteria |
| Q38414823 | Fighting microbial drug resistance: a primer on the role of evolutionary biology in public health |
| Q37690561 | Functional profiling of the gut microbiome in disease-associated inflammation |
| Q57954149 | GUT in FOCUS Symposium NOBEL FORUM, Karolinska Institutet, February 2nd 2015 |
| Q35917479 | Gastroenvironmental distress: metaphorical antecedents of the gut microbiome |
| Q35115051 | Gut Health in the era of the human gut microbiota: from metaphor to biovalue |
| Q93136819 | Gut microbiome beats two to zero host genome |
| Q33801736 | Gut microbiome composition and function in experimental colitis during active disease and treatment-induced remission |
| Q34295129 | Honor Thy Gut Symbionts Redux |
| Q90782014 | Host determinants of among-species variation in microbiome composition in drosophilid flies |
| Q38865890 | How the microbiota shapes rheumatic diseases |
| Q28655573 | Human microbiome science: vision for the future, Bethesda, MD, July 24 to 26, 2013 |
| Q40158461 | Identification of donor microbe species that colonize and persist long term in the recipient after fecal transplant for recurrent Clostridium difficile. |
| Q38726557 | Immune modulation of the brain-gut-microbe axis |
| Q36083001 | Impact of Helminth Infections and Nutritional Constraints on the Small Intestine Microbiota |
| Q42652520 | In this issue of Gut Microbes. |
| Q34238652 | In vivo efficacy of HDL-like nanolipid particles containing multivalent peptide mimetics of apolipoprotein A-I. |
| Q31150385 | Inferring human microbial dynamics from temporal metagenomics data: Pitfalls and lessons |
| Q26853123 | Inflammatory bowel disease as a model for translating the microbiome |
| Q40122112 | Influence of the pneumococcal conjugate vaccines on the temporal variation of pneumococcal carriage and the nasal microbiota in healthy infants: a longitudinal analysis of a case-control study |
| Q35587907 | Intestinal microbiota-related effects on graft-versus-host disease. |
| Q60959975 | LA39 Activates the Oxidative Phosphorylation Pathway in Porcine Intestinal Epithelial Cells |
| Q45658610 | Learned and unlearned concepts in periodontal diagnostics: a 50-year perspective |
| Q27687411 | Lung microbiome for clinicians. New discoveries about bugs in healthy and diseased lungs |
| Q34589695 | Mechanistic links between gut microbial community dynamics, microbial functions and metabolic health |
| Q34822704 | Metabolic modeling of species interaction in the human microbiome elucidates community-level assembly rules |
| Q24288894 | Metagenomics for pathogen detection in public health |
| Q38849278 | Microbial Ecology of the Human Skin |
| Q26801329 | Microbiology and ecology are vitally important to premedical curricula |
| Q35847464 | Microbiome to Brain: Unravelling the Multidirectional Axes of Communication |
| Q26781408 | Microbiomes: unifying animal and plant systems through the lens of community ecology theory |
| Q42368128 | Microbiota regulates bone marrow mesenchymal stem cell lineage differentiation and immunomodulation |
| Q100737175 | Mining zebrafish microbiota reveals key community-level resistance against fish pathogen infection |
| Q37629657 | Modeling the impact of antibiotic exposure on human microbiota |
| Q62899072 | Modelling microbiome recovery after antibiotics using a stability landscape framework |
| Q31153631 | Nasopharyngeal microbiota in healthy children and pneumonia patients |
| Q30371272 | Opportunities to assess factors contributing to the development of the intestinal microbiota in infants living in developing countries. |
| Q39270112 | Patients as Patches: Ecology and Epidemiology in Healthcare Environments. |
| Q42776890 | Peptide array based discovery of synthetic antimicrobial peptides |
| Q36920454 | Peptidoglycan from the gut microbiota governs the lifespan of circulating phagocytes at homeostasis |
| Q34030953 | Probiotic L. reuteri treatment prevents bone loss in a menopausal ovariectomized mouse model. |
| Q34828300 | Probiotics can generate FoxP3 T-cell responses in the small intestine and simultaneously inducing CD4 and CD8 T cell activation in the large intestine. |
| Q89310983 | Profiling of lung microbiota in the patients with obstructive sleep apnea |
| Q34982476 | Quantifying the impact of storage procedures for faecal bacteriotherapy in the critically endangered New Zealand parrot, the kakapo (Strigops habroptilus). |
| Q37502050 | Quantitative analysis of the human airway microbial ecology reveals a pervasive signature for cystic fibrosis |
| Q47772002 | Recent Development of Prebiotic Research-Statement from an Expert Workshop |
| Q46244124 | Restoration of the gut microbial habitat as a disease therapy |
| Q27319519 | Spatial and functional heterogeneities shape collective behavior of tumor-immune networks |
| Q42531851 | Special Issue: Gut Microbial Communities in Health and Disease |
| Q35099791 | Species-selective killing of bacteria by antimicrobial peptide-PNAs |
| Q90098536 | Specific gut microbiome members are associated with distinct immune markers in pediatric allogeneic hematopoietic stem cell transplantation |
| Q37463929 | Staphylococcus epidermidis in the human skin microbiome mediates fermentation to inhibit the growth of Propionibacterium acnes: implications of probiotics in acne vulgaris. |
| Q40140126 | Sustainable therapies by engineered bacteria |
| Q64929686 | Synthesis of glycopolymers with specificity for bacterial strains via bacteria-guided polymerization. |
| Q37087480 | Targeted Treatment for Bacterial Infections: Prospects for Pathogen-Specific Antibiotics Coupled with Rapid Diagnostics |
| Q28069455 | The Gut Microbiome as Therapeutic Target in Central Nervous System Diseases: Implications for Stroke |
| Q36615138 | The Human Microbiome Project strategy for comprehensive sampling of the human microbiome and why it matters |
| Q39077406 | The Influence of the Microbiome on Allergic Sensitization to Food |
| Q42274713 | The Origins and Drivers of Insulin Resistance |
| Q26768542 | The Thanatomicrobiome: A Missing Piece of the Microbial Puzzle of Death |
| Q26825590 | The application of ecological theory toward an understanding of the human microbiome |
| Q35117031 | The gut microbiota in mouse models of inflammatory bowel disease |
| Q26749316 | The healthy human microbiome |
| Q33754027 | The interplay between host immune cells and gut microbiota in chronic inflammatory diseases |
| Q33664898 | The microbiome in inflammatory bowel disease: current status and the future ahead |
| Q33610082 | The prevalence of species and strains in the human microbiome: a resource for experimental efforts |
| Q38016806 | Therapeutic modulation of microbiota-host metabolic interactions. |
| Q33915072 | Tipping elements in the human intestinal ecosystem |
| Q34691436 | Towards a predictive systems-level model of the human microbiome: progress, challenges, and opportunities |
| Q36045881 | Universality of human microbial dynamics |
| Q42198288 | Why infectious diseases |
Search more.